ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)

Volume 17, 9 Issues, 2017

Download PDF Flyer

Current Cancer Drug Targets

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 68th of 213 in Oncology

Submit Abstracts Online Submit Manuscripts Online

Ruiwen Zhang
Texas Tech University Health Sciences Center
1300 Coulter Drive
Amarillo, TX 79106

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.992
5 - Year: 3.412

Abstracts Ahead of Print

Clinical evidence on the magnitude of change in growth pathway activity in relation to Tamoxifen resistance is required

Sepideh Mansouri, Leila Farahmand, Azin Teymourzadeh and Keivan Majidzadeh-A.

View Abstract

Aldose reductase inhibitor, fidarestat prevents high-fat diet-induced intestinal polyps in ApcMin/+ mice.

Ashish Saxena, Ravinder Tammali, Kota V Ramana and Satish K Srivastava.

View Abstract

TGF-β1 Causes EMT by regulating N-Acetyl Glucosaminyl Transferases via Downregulation of Non Muscle Myosin II-A through JNK/P38/PI3K pathway in lung cancer

Ghulam Jilany Khan, Yingsheng Gao, Ming Gu, Lai Wang, Sara Khan, Farah Naeem, Bashir Alsiddig Yousef, Debmalya Roy, Herve Semukunzi, Shengtao Yuan and Li Sun.

View Abstract

Cell-derived Exosomes as Promising Carriers for Drug Delivery and Targeted Therapy

Xinyi Wang, Haiyang Zhang, Haiou Yang, Ming Bai, Tao Ning, Shuang Li, Jialu Li, Ting Deng, Guoguang Ying and Yi Ba.

View Abstract

The Safety, Efficacy and Therapeutic Potential of Histone Deacetylase Inhibitors with Special Reference to Panobinostat in Gastrointestinal Tumors: A Review of Preclinical and Clinical Studies

Avineesh Singh, Preeti Patel, Jageshwar, Vijay Kumar Patel, Deepak Kumar Jain, M Kamal and Harish Rajak.

View Abstract

Recent Updates on the Therapeutic Potential of HER2 Tyrosine Kinase Inhibitors for the Treatment of Breast Cancer

Heena Singla, Anjana Munshi, Raja Paramjit Singh Banipal and Vinod Kumar.

View Abstract

The Structural Bioinformatics analysis of Biophenolic Lignan-Estrogen Receptor interaction

Farzaneh Mohamadyar-Toupkanlou, Mina Esfandiari, Mahshid Sadat Kashef-Saberi, Mahboubeh Kabiri Renani and Masoud Soleimani.

View Abstract

Evaluation of anti-cancer activity of stilbene and methoxydibenzo[b,f]oxepin derivatives

Damian Garbicz , Damian Mielecki , Michał Wrzesiński , Tomasz Pilżys, Michał Marcinkowski , Jan Piwowarski , Janusz Dębski, Ewelina Palak, Przemysław Szczeciński, Hanna Krawczyk and Elżbieta Grzesiuk.

View Abstract

An update on circumventing multidrug resistance in cancer by targeting P-glycoprotein

Xiaoqian Yang, Xiaoduan Li, Zhenfeng Duan and Xipeng Wang.

View Abstract

p53-Mdm2 interaction inhibitors as novel nongenotoxic anticancer agents

Surendra Kumar Nayak, Gopal L. Khatik, Rakesh Narang, Vikramdeep Monga and Harish Kumar Chopra.

View Abstract

6th annual Cancer Vaccines Conference

Related Journals

Related eBooks

Webmaster Contact: Copyright © 2017 Bentham Science